Objectives: The aim of the present study was to evaluate selected acute phase proteins (APPs) in 61 cats (mainly stray, domestic shorthair cats, aged 2 months to 17 years, 39 males and 22 females) presented with acute trauma at a university teaching hospital. Methods: Serum amyloid A (SAA), haptoglobin (Hp), ceruloplasmin and albumin were compared with APPs in a population of healthy cats with similar demographic data and in cats with trauma, considering demographic data, trauma type and localisation (craniofacial and/or vertebral and/or appendicular, thoracic, abdominal and localised, multiple or polytrauma), anti-inflammatory treatment and outcome (survival to discharge or death). APPs were correlated to age, rectal temperature, body weight, total leukocyte, neutrophil, band neutrophil and lymphocyte counts, total protein, albumin:globulin ratio, base excess and hospitalisation duration. Results: In cats with acute trauma, the median concentrations of SAA and Hp were significantly higher than in healthy control cats (90.5 vs 0.6 mg/ml and 130.7 vs 58.8 mg/dl, respectively; P <0.0001) and showed a median 150-fold increase and 2.2-fold increase, respectively, relative to healthy cats. Albumin was significantly lower in cats with trauma compared with healthy cats (3.4 vs 3.8 g/dl, respectively; P <0.0001) and in cats with vertebral trauma compared with cats with other trauma localisations. SAA showed a significantly positive correlation with length of hospitalisation ( r = 0.488; P = 0.0003) in 50 surviving cats, while albumin showed a significantly negative correlation ( r = –0.426; P = 0.0020), in addition to a negative correlation with band neutrophils ( r = –0.329; P = 0.0097). In 15 cats with trauma in which APPs were also evaluated at discharge, SAA was significantly lower than at admission. Conclusions and relevance: Acute trauma in cats is associated with significant increases in SAA and Hp and decreases in albumin. Testing SAA and albumin in cats with acute trauma may provide a useful prognostic indicator of length of hospitalisation, but no evaluated APPs are of prognostic value for survival.